CSPC Pharmaceutical Group (FRA:CVGU) Cash Flow for Dividends: €0 Mil (TTM As of Dec. 2025)


FRA:CVGU CSPC Pharmaceutical Group Ltd FRA:CVGU
88 GF Score
Price €2.68
GF Value €2.63
! 4 Warning Signs
View Full Analysis

What is CSPC Pharmaceutical Group Cash Flow for Dividends?

CSPC Pharmaceutical Group FRA:CVGU +3.88% 88 Cash Flow for Dividends is €0 Mil as of Dec. 2025. GuruFocus rates FRA:CVGU with a GF Score™ of 88/100 and a GF Value™ of €2.63. The stock has 4 warning signs investors should review.

CSPC Pharmaceutical Group's cash flow for dividends for the three months ended in Dec. 2025 was €0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was €0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

CSPC Pharmaceutical Group's annual payment of dividends increased from Dec. 2023 (€-350 Mil) to Dec. 2024 (€-424 Mil) but then declined from Dec. 2024 (€-424 Mil) to Dec. 2025 (€-303 Mil).

CSPC Pharmaceutical Group Cash Flow for Dividends Related Terms

CSPC Pharmaceutical Group Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for CSPC Pharmaceutical Group's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CSPC Pharmaceutical Group Cash Flow for Dividends Chart

CSPC Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -234.93 -283.94 -350.13 -424.18 -302.81

CSPC Pharmaceutical Group Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:CVGU
88GF Score
CSPC Pharmaceutical Group Ltd FRA:CVGU
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CSPC Pharmaceutical Group Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of €0 Mil mean?
CSPC Pharmaceutical Group (FRA:CVGU) has a Cash Flow for Dividends of €0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for CSPC Pharmaceutical Group and its competitors.
Is CSPC Pharmaceutical Group's Cash Flow for Dividends too high?
CSPC Pharmaceutical Group's current Cash Flow for Dividends is €0 Mil. Overall, CSPC Pharmaceutical Group has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does CSPC Pharmaceutical Group's Cash Flow for Dividends compare to LLY and JNJ?
CSPC Pharmaceutical Group's Cash Flow for Dividends of €0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for CSPC Pharmaceutical Group and its competitors. CSPC Pharmaceutical Group's current Cash Flow for Dividends is €0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CSPC Pharmaceutical Group stock overvalued right now?
CSPC Pharmaceutical Group (FRA:CVGU) has a current Cash Flow for Dividends of €0 Mil. The stock's GF Value™ is €2.63, compared to a current price of €2.68 — trading 1.9% above its estimated fair value. The current Cash Flow for Dividends is €0 Mil. CSPC Pharmaceutical Group's overall GF Score™ is 88/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For CSPC Pharmaceutical Group (FRA:CVGU), the current Cash Flow for Dividends is €0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CSPC Pharmaceutical Group (FRA:CVGU) Overvalued in 2026?

Based on GuruFocus' analysis, CSPC Pharmaceutical Group stock appears to be overvalued. The current stock price of €2.68 is trading 1.9% above its estimated GF Value™ of €2.63.

Key valuation signals for FRA:CVGU:

  • Cash Flow for Dividends: €0 Mil
  • GF Value™: €2.63 vs. price of €2.68 (1.9% above fair value)
  • GF Score™: 88/100 with 4 warning signs

No single metric tells the full story. See the FRA:CVGU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CSPC Pharmaceutical Group Business Description

Address No.896 Zhongshandong Street, Gaoxin District, Hebei Province, Shijiazhuang, CHN, 050035
CSPC Pharmaceutical Group LTD is engaged in the manufacture and sale of pharmaceutical products. The group's segments include: Finished drugs, consisting research and development, manufacture and sale of pharmaceutical products and license fee income; Bulk products, that manufacture and sale of vitamin C, and antibiotic products in bulk powder form; and Functional food and others, that manufacture and sale of functional food products (including caffeine food additives, anhydrous glucose, acarbose and vitamin C buccal tablets), provision of healthcare service and others. It derives maximum revenue from Finished Products segments. Geographically, the company operates in Chinese Mainland, which Chinese Mainland generates maximum revenue; Other Asian regions; Europe; North America; and Others.
88GF Score

Get the complete analysis for FRA:CVGU

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.68
Price
€2.63
GF Value